Literature DB >> 3129539

Adrenal cortex hormones in male epileptic patients before and during a 2-year phenytoin treatment.

Z Ostrowska1, B Buntner, D Rościszewska, I Guz.   

Abstract

Serum levels of progesterone, cortisol and phenytoin as well as the excretion of 17-OHCS were determined in 45 male epileptics before and during 24 months of the therapy. A significant decrease of the hormones was found in untreated patients. Phenytoin administration caused further decrease of cortisol and its metabolite 17-OHCS levels and a compensation of progesterone serum concentration.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3129539      PMCID： PMC1032863          DOI： 10.1136/jnnp.51.3.374

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  13 in total

1.  EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN.

Authors:  E E WERK; J MACGEE; L J SHOLITON
Journal:  J Clin Invest       Date:  1964-09       Impact factor: 14.808

2.  Determination of phenobarbital and phenytoin in serum by ultraviolet spectrophotometry.

Authors:  O V Olesen
Journal:  Scand J Clin Lab Invest       Date:  1967       Impact factor: 1.713

3.  Inhibitory effect of diphenylhydantoin on the feedback control of corticotrophin release.

Authors:  V H Asfeldt; J Buhl
Journal:  Acta Endocrinol (Copenh)       Date:  1969-07

4.  Effect of diphenylhydantoin on cortisol kinetics in humans.

Authors:  Y Choi; K Thrasher; E E Werk; L J Sholiton; C Olinger
Journal:  J Pharmacol Exp Ther       Date:  1971-01       Impact factor: 4.030

5.  Interference in the effect of dexamethasone by diphenylhydantoin.

Authors:  E E Werk; Y Choi; L Sholiton; C Olinger; N Haque
Journal:  N Engl J Med       Date:  1969-07-03       Impact factor: 91.245

6.  Plasma proteins in patients on long-term antiepileptic treatment.

Authors:  R Olsson; L Hellner; G Lindstedt; P A Lundberg; A C Teger-Nilsson
Journal:  Clin Chem       Date:  1983-04       Impact factor: 8.327

7.  Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. III. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids, lipoproteins and cortisol.

Authors:  R Rogozea; V Florea-Ciocoiu; C Bălăiţă; N Luca
Journal:  Neurol Psychiatr (Bucur)       Date:  1982 Apr-Jun

8.  [Urinary excretion of 17-hydroxycorticosteroids and 17-ketosteroids in women with epileptic seizures during the premenstrual period].

Authors:  D Rościszewska; B Buntner
Journal:  Neurol Neurochir Pol       Date:  1975 May-Jun       Impact factor: 1.621

9.  Plasma prolactin and cortisol concentrations in epileptic patients during the night.

Authors:  A Cavallo; D C Moore; A Nahori; A Beaumanoir; P C Sizonenko
Journal:  Arch Neurol       Date:  1984-11

10.  Serum prolactin and cortisol concentrations after grand mal seizures.

Authors:  R J Abbott; M C Browning; D L Davidson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154
View more
  1 in total

Review 1.  Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids.

Authors:  Hélène Prigent; Virginie Maxime; Djillali Annane
Journal:  Crit Care       Date:  2004-05-25       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.